IGFBP3 and type 1 diabetes mellitus: In type 1 diabetes, where IGF-I and IGFBP-3 levels are decreased[302], substitutive rhIGF-I/IGFBP-3 therapy enhances protein[303] and glucose metabolism by controlling both endogenous glucose output and peripheral glucose uptake[304].